Symplmed Pharmaceuticals LLC

Quick facts

Phase 3 pipeline

• XOMA 985 · Immunology
  XOMA 985 is a monoclonal antibody that targets and inhibits IL-15, a key cytokine involved in immune cell activation and proliferation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Symplmed Pharmaceuticals LLC portfolio CI brief
• Symplmed Pharmaceuticals LLC pipeline updates RSS